In addition to lobbying for more access to psychedelic medicines, groups such as the Multidisciplinary Association for Psychedelic Studies (MAPS) have been laying the groundwork to develop full-service psychedelic-assisted therapy clinics.
Through developing protocols and training psychotherapists in psychedelic-assisted therapy methods, slowly but surely, their work is paying off. Several clinics are now operating and offering psychedelic-assisted therapy services around the world.
Currently, the scope and scale of what these clinics can provide are still somewhat limited depending on their location, but the trend is clearly towards a more robust and thriving clinical landscape, complete with highly-trained, certified personnel and institutional oversight.
Third Wave has created its own psychedelic provider directory for you to find curated psychedelic-assisted therapy clinics. All clinics listed have either been verified or rigorously vetted by the Third Wave team, so you can feel confident knowing that these clinics are worth considering in this vulnerable and transformative experience. We will continually add more high quality clinics as time moves forward, so be sure to bookmark the directory or share it with loved ones looking for support.
FIND PSYCHEDELIC CLINICS
Psychedelic-Assisted Therapy Clinics Offerings
Psychedelic Integration Therapy
One way clinics get around the myriad legal issues surrounding the use of psychedelics in therapeutic settings is through integration therapy. Clinics who offer this service have therapists on staff who are trained in helping people process their psychedelic experiences for spiritual growth and/or therapeutic purposes.
The clinics do not provide (nor do they ostensibly condone the use of) psychedelics, but rather provide insight into how a person might integrate the lessons from a psychedelic experience into their own personal healing process.
Ketamine-Assisted Psychotherapy (KAP) is a short term, intensive treatment used for treatment-resistant depression, anxiety, PTSD, OCD, and bipolar depression. It’s one of the few legal psychedelic-assisted therapies currently used in practice in the United States and other parts of the world. Visit our directory to find legal ketamine clinics.
Ibogaine has been successfully used alongside psychotherapy and social support to treat addiction. But despite all the evidence and thousands of personal accounts of its success, it still remains illegal in most parts of the world.
Two glowing exceptions (among others) are Mexico and New Zealand. Ibogaine clinics in these countries have reported successful treatment protocols for opioid addiction. Organizations continue to lobby for more direct access to resources to study ibogaine in treating addiction.
If you’re considering attending an ibogaine treatment clinic, make sure they’re a member of The Global Ibogaine Alliance (GITA) and trained in IbogaSafe protocols. They should also adhere to the clinical guidelines set forth by GITA.
Other Psychedelic-Assisted Therapies in Clinical Trials
Despite the many hurdles in studying psychedelics in a clinical setting—legal and otherwise—exciting research is still being done exploring the power and scope of psychedelic medicines.
Early results are extremely promising and regulatory bodies appear to be more and more open to allowing these studies to continue. If this trend continues, it’s only a matter of time before the following therapies are offered in clinics throughout the world:
- Psilocybin-Assisted Therapy – Perhaps the most well-known research currently being conducted is with psilocybin-assisted therapy. Clinical trials have shown great promise in treating end-of-life anxiety and depression in terminally ill patients and more studies are being conducted on treatment-resistant depression.
- MDMA-Assisted Therapy – A growing number of small-scale clinical trials are currently exploring the therapeutic value of MDMA-assisted psychotherapy in treating post-traumatic stress disorder (PTSD). Early results are quite promising, leading many in the industry to predict wider-scale access to MDMA as a treatment option as early as 2021.
- LSD-Assisted Therapy – MAPS recently conducted a small pilot study in Switzerland showing promise for the use of LSD in treating anxiety.
- Ayahuasca-Assisted Therapy – Preliminary research into the therapeutic effect of ayahuasca suggests that it may decrease substance use by promoting personal or spiritual insights and self-awareness.